Medical/Pharmaceuticals
VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update
Conference call to take place on Thursday March 31 at 08:00a.m. Eastern time AUSTIN, Texas, March 28, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Thursday March 31, 08.00a.m. Eastern time to discuss its financial and ...
2022-03-29 04:25
1838
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%
Financial Highlights of the year ended December 31, 2021: * Revenue amounted to RMB2,104.1 million, representing a year-on-year (YoY) increase of 201.9% * Gross profit amounted to RMB651.0 million, representing a YoY increase of 113.5% * Adjusted Non-IFRS net profit amounted to RMB352.5 mil...
2022-03-29 01:01
2367
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%
Financial Highlights of the year ended December 31, 2021: * Revenue amounted to RMB2,104.1 million, representing a year-on-year (YoY) increase of 201.9% * Gross profit amounted to RMB651.0 million, representing a YoY increase of 113.5% * Adjusted Non-IFRS net profit amounted to RMB352.5 mil...
2022-03-29 00:49
2323
Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany
BEIJING, March 28, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (hereafter referred to as "Biocytogen") announced the opening of the Biocytogen Europe Innovation Center (BEIC) in Heidelberg,Germany. Local government representatives, clinical experts, and colleagues and col...
2022-03-28 21:30
1816
Clarity's US-based Cu-64 SAR-bisPSMA trial in prostate cancer opens for recruitment
SYDNEY, March 28, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that the diagnostic 64Cu SAR-bisPSMA trial (COBRA NCT05249127 <...
2022-03-28 21:06
1562
First-ever integrated EEG and neurotherapeutics device iSyncWave wins the 2022 Red Dot Design Award
SEOUL, South Korea, March 28, 2022 /PRNewswire/ -- AI-based digital mental
healthcare platform company iMediSync has announced that their product
"iSyncWave" has won the 2022 Red Dot Design Award for its innovative and
creative design asa dry EEG headset.
2022-03-28 20:00
1371
Tigermed Reports Strong 2021 Full-Year Results
HANGZHOU, China, March 28, 2022 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its an...
2022-03-28 19:10
2050
At the 2022 AAD Annual Meeting, Senhwa Presents Positive Initial Data from Clinical Trial of Silmitasertib Used to Treat Patients with Advanced Basal Cell Carcinoma
* Early results showed 2 laBCC (locally advanced Basal Cell Carcinoma) subjects out of 10 experienced a Partial Response (30% decrease in tumor size) at week #24. * The first biopsy analysis in the laBCC subject showed a more than 90% decrease of GLI-1 expression at week #8 (GLl-1 is involved...
2022-03-28 19:00
1191
Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels
HAMBURG, Germany, March 28, 2022 /PRNewswire/ -- Vela Diagnostics announced today the launch of its new OncoKey® SL 60 and 525 Plus Panels. These next-generation sequencing (NGS)-based panels are intended for detection of DNA and RNA cancer biomarkers from formalin-fixed paraffin-embedded (FFPE) ...
2022-03-28 15:00
1327
Hyperflex® Balloon Catheter by Endovastec™ Receives Marketing Approval in Japan
SHANGHAI, March 28, 2022 /PRNewswire/ -- Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently announced that it has received registration approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) for its independently-developed Hyperflex® Balloon Catheter (...
2022-03-28 12:29
2153
InnoCare Announces Approval of Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China
BEIJING, March 27, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the company has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical Products Administration) for its TYK2 JH2 allosteric inhibitor ICP-488, which is the Compan...
2022-03-28 10:48
1367
miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore
High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, andLeonie Hill Capital, a Sin...
2022-03-28 09:09
1950
Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages
NCCN Guidelines for Patients: Colorectal Cancer Screening now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer. PLYMOUTH MEETING, Pa.March 28, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today ann...
2022-03-28 09:07
2325
Innovent and Lilly Expand Strategic Partnership in Oncology
SAN FRANCISCO and INDIANAPOLIS and SUZHOU, China, March 28, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and...
2022-03-28 08:00
4163
Ascletis Announces the Latest Results of the Preclinical Studies of Two Novel Anti-Cancer Drug Candidates, ASC61 and ASC60, to be presented at AACR Annual Meeting 2022
HANGZHOU, China and SHAOXING, China, March 27, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that the latest preclinical research results of the company's two novel anti-cancer drug candidates, ASC61, an oral PD-L1 inhibitor and ASC60, an oral fatty acid synthase (FASN) i...
2022-03-27 18:30
3179
Kintor Pharma Announces 2021 Business Progress and Annual Results
SUZHOU, China, March 25, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year endedDecember 3...
2022-03-26 01:23
7658
Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG
SHANGHAI, March 25, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG (generic name: serplulimab injection) has been approved by the National Medical Products Administration (NMPA)for the treatment of adult ...
2022-03-25 21:24
4942
Abcam the most awarded company at 2022 industry awards
CAMBRIDGE, England, March 25, 2022 /PRNewswire/ -- Abcam
2022-03-25 20:40
4251
CGTN: Peng Liyuan addresses video conference on World TB Day 2022
BEIJING, March 25, 2022 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill ambassador for tuberculosis (TB) and HIV/AIDS, attended a video conference for World Tuberculosis Day 2022 on Thursday. &amp;nbsp; "In recent years, tha...
2022-03-25 11:20
3387
Modern Chinese Medicine Announces Year 2021 Annual Results
Solid growth driven by extensive distribution network and strong R&D PERFORMANCE HIGHLIGHTS * The Group posted a consolidated revenue of approximately RMB360.7 million for the year ended31 December 2021, representing an increase of approximately 16.8% * For the year ended 31 December 2021, t...
2022-03-25 10:39
3751
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
9970
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
6670
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
5807
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
4898
